Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rlf–Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer
Metamia Ciampricotti, Triantafyllia Karakousi, Allison L. Richards, et al.
Cancer Discovery (2021) Vol. 11, Iss. 12, pp. 3214-3229
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation
Smruthy Sivakumar, Jay A. Moore, Meagan Montesion, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1572-1591
Open Access | Times Cited: 65
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
Lőrinc Sándor Pongor, Christopher W. Schultz, Lorenzo Rinaldi, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 928-949
Open Access | Times Cited: 54
Killing SCLC: insights into how to target a shapeshifting tumor
Kate D. Sutherland, Abbie S. Ireland, Trudy G. Oliver
Genes & Development (2022) Vol. 36, Iss. 5-6, pp. 241-258
Open Access | Times Cited: 52
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
Triparna Sen, Nobuyuki Takahashi, Subhamoy Chakraborty, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 8, pp. 610-627
Closed Access | Times Cited: 14
Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs
Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 804-827
Open Access | Times Cited: 13
Genetically-engineered mouse models of small cell lung cancer: the next generation
Matthew G. Oser, David MacPherson, Trudy G. Oliver, et al.
Oncogene (2024)
Open Access | Times Cited: 11
A multiplexed in vivo approach to identify driver genes in small cell lung cancer
Myung Chang Lee, Hongchen Cai, Christopher W. Murray, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111990-111990
Open Access | Times Cited: 19
Small cell lung cancer profiling: an updated synthesis of subtypes, vulnerabilities, and plasticity
Esther Redín, Àlvaro Quintanal-Villalonga, Charles M. Rudin
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 935-946
Closed Access | Times Cited: 7
Relationships of tumor differentiation and immune infiltration in gastric cancers revealed by single-cell RNA-seq analyses
Xin Zhou, Jingwei Yang, Yongqu Lu, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 15
Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration
Changshu Li, Jun Shao, Peiyi Li, et al.
Cancer Letters (2023) Vol. 577, pp. 216365-216365
Open Access | Times Cited: 14
Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer
John B. Finlay, Abbie S. Ireland, Sarah B. Hawgood, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1086-1105.e13
Open Access | Times Cited: 4
Formation of malignant, metastatic small cell lung cancers through overproduction of cMYC protein in TP53 and RB1 depleted pulmonary neuroendocrine cells derived from human embryonic stem cells
Huanhuan Joyce Chen, Eric E. Gardner, Yajas Shah, et al.
(2025)
Open Access
Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics
Subhadeep Das, Shayak Samaddar
Cancers (2025) Vol. 17, Iss. 2, pp. 255-255
Open Access
MethPriorGCN: a deep learning tool for inferring DNA methylation prior knowledge and guiding personalized medicine
Jie Ni, Bin Li, Shumei Miao, et al.
Briefings in Bioinformatics (2025) Vol. 26, Iss. 2
Open Access
Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review
Jiaqi Xiong, Ranya Barayan, Alexander V. Louie, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 521-542
Open Access | Times Cited: 14
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype‐definition in small cell lung cancer
Doron Tolomeo, Debora Traversa, Santina Venuto, et al.
Genes Chromosomes and Cancer (2022) Vol. 62, Iss. 7, pp. 377-391
Open Access | Times Cited: 13
YES1 Is a Druggable Oncogenic Target in SCLC
Esther Redín, Eva M. Garrido-Martín, Karmele Valencia, et al.
Journal of Thoracic Oncology (2022) Vol. 17, Iss. 12, pp. 1387-1403
Open Access | Times Cited: 12
WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer
Kee‐Beom Kim, Dong-Wook Kim, Youngchul Kim, et al.
Cancer Research (2022) Vol. 82, Iss. 22, pp. 4219-4233
Open Access | Times Cited: 11
Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus–Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas
Emily Hartsough, Mari Mino‐Kenudson, Jochen K. Lennerz, et al.
American Journal of Clinical Pathology (2023) Vol. 159, Iss. 4, pp. 395-406
Open Access | Times Cited: 6
Advances in biology and novel treatments of SCLC: The four-color problem in uncharted territory
Jumpei Kashima, Yusuke Okuma
Seminars in Cancer Biology (2022) Vol. 86, pp. 386-395
Closed Access | Times Cited: 9
Population-wide gene disruption in the murine lung epithelium via AAV-mediated delivery of CRISPR-Cas9 components
Honglin Chen, Steffen Durinck, Hetal Patel, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 27, pp. 431-449
Open Access | Times Cited: 8
An enhanced Eco1 retron editor enables precision genome engineering in human cells from a single-copy integrated lentivirus
Matthew A. Cattle, L Aguado, Samantha Sze, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification ofMYCparalogs
Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Applications of CRISPR technology to lung cancer research
Anabel Sorolla, Eva Parisi, Maria Alba Sorolla, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 1, pp. 2102610-2102610
Open Access | Times Cited: 9
Applications and advancements of CRISPR-Cas in the treatment of lung cancer
Lei Pan, Yixin Ju, Fenfen Peng, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top